NOTCH3 and lung cancer: Based on our study results, we concluded that BH substantially suppressed Notch3 signaling in human lung cancer, resulting in powerful antitumor activity in human lung cancer both in vitro and in vivo, and that it can improve the sensitivity of resistant NSCLC to gefitinib.